Produkty 3862-25-7

CAS 3862-25-7 występuje w naszej ofercie pod nazwami: 7 ALPHA-HYDROXYCHOLESTENONE, 7-Hydroxy-4-cholesten-3-one-D7, Cholesterol Impurity 36, 7alpha-Hydroxy-4-cholesten-3-one, >95% (HPLC), 7α-Hydroxy-4-cholesten-3-one, >95% (HPLC). Oferty producentów: Sigma-Aldrich, Biosynth, Chemat Brand, TRC, TargetMol. Dostępne opakowania: 10MG, 1MG, 2mg, 5mg, on request, 25mg, 50mg, Get quote.

7 ALPHA-HYDROXYCHOLESTENONE
Sigma-Aldrich
  • opakowanie: 10MG, 1MG
  • Warianty: 2
od 1800,00
Zobacz produkt
7-Hydroxy-4-cholesten-3-one-D7
Biosynth
  • opakowanie: 1mg, 2mg, 5mg
  • Warianty: 3
Zobacz produkt
Cholesterol Impurity 36
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
7alpha-Hydroxy-4-cholesten-3-one, >95% (HPLC)
TRC
  • opakowanie: 1mg, 5mg
  • Warianty: 2
Zobacz produkt
7α-Hydroxy-4-cholesten-3-one, >95% (HPLC)
TRC
  • opakowanie: 25mg
  • Warianty: 1
Zobacz produkt
7α-Hydroxy-4-cholesten-3-one/ 99.14% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 5
od 2019,55
Zobacz produkt
7α–hydroxy–4–Cholesten–3–one
GLPBio
  • opakowanie: 1mg
  • Warianty: 1
od 1888,86
Zobacz produkt
7α-Hydroxy-4-cholesten-3-one
Biosynth
  • opakowanie: 1mg, 2mg, 5mg, 25mg
  • Warianty: 5
Zobacz produkt
7ALPHA-HYDROXY-4-CHOLESTEN-3-ONE
Sigma-Aldrich
  • opakowanie: 1MG
  • Warianty: 1
od 2012,00
Zobacz produkt
7α-Hydroxy-4-cholesten-3-one, 97+%, 97+%
Chemat
  • opakowanie: 1mg, 5mg, 10mg
  • Warianty: 3
od 2392,40
Zobacz produkt
7α-Hydroxy-4-cholesten-3-one (Standard)
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
7α-Hydroxy-4-cholesten-3-one, 99.60%
MedChemExpress
  • opakowanie: 5 mg, 1 mg, 10 mg, 25 mg
  • Warianty: 4
od 1801,13
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(7R,8S,9S,10R,13R,14S,17R)-7-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one (CAS 3862-25-7) to związek chemiczny o wzorze sumarycznym C27H44O2 i masie molowej 400.6 g/mol. Nazwa systematyczna IUPAC: (7R,8S,9S,10R,13R,14S,17R)-7-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one. InChIKey: IOIZWEJGGCZDOL-RQDYSCIWSA-N.

Dane identyfikacyjne
Wzór sumarycznyC27H44O2
Masa molowa400.6 g/mol
Nazwa IUPAC(7R,8S,9S,10R,13R,14S,17R)-7-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
InChIKeyIOIZWEJGGCZDOL-RQDYSCIWSA-N
SMILESC[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](CC4=CC(=O)CC[C@]34C)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 7alpha-Hydroxy-4-cholesten-3-one, 7alpha-Hydroxycholest-4-en-3-one, Cholest-4-en-7alpha-ol-3-one, 7 alpha-hydroxy-4-cholesten-3-one, cholest-4-en-7 alpha-ol-3-one, 7-hydroxy-4-cholesten-3-one, 7|A-Hydroxy-4-cholesten-3-one, 7 alpha-3ox-C, 7-alpha-hydroxy-4-cholesten-3-one, 7a-Hydroxy-4-cholesten-3-one
Powiązane formy tego związku
(7S,8S,9S,10R,13R,14S,17R)-7-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C27H44O2
(7S,8S,9S,10R,13R,14S,17R)-7-hydroxy-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-6-(trideuteriomethyl)heptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C27H44O2
Izomery (ten sam wzór sumaryczny)
(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O2
[(2E)-3,7-dimethylocta-2,6-dienyl] (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoate C27H44O2
trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol C27H44O2
(1S)-3-[(Z)-2-[(1R,3aR,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol C27H44O2
(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-7,7,7-trideuterio-6-hydroxy-6-(trideuteriomethyl)heptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O2
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R)-4-[(2S)-3,3-dimethyloxiran-2-yl]butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O2
(1R,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O2
(8S,9S,10R,13R,14S,17R)-17-[(2R,6R)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C27H44O2
(3S,9R,10S,13R,14R,17R)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O2
(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-7-one C27H44O2